Literature DB >> 32064542

Radiation techniques in aggressive pituitary tumours and carcinomas.

Frederic Castinetti1.   

Abstract

Defining the role of radiation techniques in treatment of aggressive pituitary tumours and carcinomas is a difficult task: indeed, studies reported in the literature on this topic can probably be counted on the fingers of one hand. To try to better define these roles, it is thus necessary to extrapolate based on anti-secretory and anti-tumor efficacy reported in studies on non-selected pituitary tumours, regardless of their pathological status and intrinsic aggressiveness. Generally, radiation techniques are delivered as part of a multimodal treatment, usually with the primary aim of controlling tumor volume. Side-effects need to be divided into short and long-term, also depending on the overall prognosis of the tumour, since hypopituitarism will likely appear in the majority of patients, extra-pituitary side-effects, which have been reported after a significant delay after the procedure, can only be considered in patients with less aggressive pituitary tumours. In this review, we will first detail the different modalities of radiation techniques and the inherent limits of each technique depending on the volume and the localization of the tumour. We will then discuss the anti-tumour and anti-secretory efficacy of radiation techniques in aggressive pituitary tumors, either as a single treatment or as part of a multimodal treatment. Finally we will discuss the technique-specific side-effects.

Entities:  

Keywords:  Acromegaly; Bevacizumab; Carcinoma; Cushing’s disease; Fractionated stereotactic radiotherapy; Gamma knife; Non-functioning pituitary tumors; Pituitary; Prolactinoma; Radiotherapy; Temozolomide

Year:  2020        PMID: 32064542     DOI: 10.1007/s11154-020-09543-y

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  5 in total

Review 1.  Diagnosis and treatment of refractory pituitary adenomas: a narrative review.

Authors:  Xiaohai Liu; Congxin Dai; Ming Feng; Mingchu Li; Ge Chen; Renzhi Wang
Journal:  Gland Surg       Date:  2021-04

Review 2.  Aggressive prolactinoma (Review).

Authors:  Ana Valea; Florica Sandru; Aida Petca; Mihai Cristian Dumitrascu; Mara Carsote; Razvan-Cosmin Petca; Adina Ghemigian
Journal:  Exp Ther Med       Date:  2021-11-24       Impact factor: 2.447

Review 3.  Aggressive pituitary tumours and pituitary carcinomas.

Authors:  Gérald Raverot; Mirela Diana Ilie; Hélène Lasolle; Vincent Amodru; Jacqueline Trouillas; Frédéric Castinetti; Thierry Brue
Journal:  Nat Rev Endocrinol       Date:  2021-09-07       Impact factor: 43.330

4.  Sprouting Angiogenesis in Human Pituitary Adenomas.

Authors:  Jie Zhou; Yaomin Hu; Wende Zhu; Chuansheng Nie; Wenxiu Zhao; Alexander T Faje; Kay E Labelle; Brooke Swearingen; Hang Lee; E Tessa Hedley-Whyte; Xun Zhang; Pamela S Jones; Karen K Miller; Anne Klibanski; Yunli Zhou; Roy J Soberman
Journal:  Front Oncol       Date:  2022-05-05       Impact factor: 5.738

5.  Synchronous pituitary and pineal gland lesions presenting with panhypopituitarism in a patient with widespread colorectal cancer: a case report.

Authors:  Tristan Struja; Joël Capraro
Journal:  Oxf Med Case Reports       Date:  2021-05-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.